eduKateSG · Why Science?
Design the hand-off, not only the device
Use FDA’s interoperability guidance through intended scenarios, electronic interfaces, information meaning, timing, integrity, availability, human factors, cybersecurity, testing and labeling.
Connected medical devices can share measurements, settings and commands with monitors, records and other equipment. The benefit appears only when the receiving system understands the information and the combined workflow remains safe.
FDA’s final interoperability guidance treats electronic interfaces as design features. It recommends clear intended scenarios, interface specifications, risk management, verification and validation, premarket information and labeling.
Did you know? A connection can succeed electrically and still fail clinically if units, timestamps, patient identity or message meaning do not match. Interoperability includes using exchanged information safely, not merely moving bytes.
This guide supports systems-engineering and science literacy. It does not certify compatibility between particular products.
Chapter index
Chapters 1–9: scenario, information and interface requirements
- 1. Interoperability means exchange and use
- 2. The intended scenario frames design
- 3. Externally facing interfaces need description
- 4. Direction of exchange matters
- 5. Information models preserve meaning
- 6. Timeliness is a safety property
- 7. Integrity must survive the route
- 8. Availability needs failure behaviour
- 9. The interface should reject unsafe inputs
Chapters 10–17: risk controls, testing, labeling and change
- 10. Human factors connect systems
- 11. Cybersecurity is an end-to-end concern
- 12. Standards can support compatibility
- 13. Risk analysis follows interaction hazards
- 14. Testing should include representative partners
- 15. Labeling defines compatible use
- 16. Updates can break interoperability
- 17. A complete interface receipt supports review
Interoperability becomes safe when an electronic interface is treated as part of the medical-device design. FDA describes interoperable medical devices as devices able to exchange and use information through an electronic interface with another medical or nonmedical product, system or device. This turns connectivity from a convenience into an engineering responsibility.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about interoperability means exchange and use? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for interoperability means exchange and use. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for interoperability means exchange and use, its identifier or version context, and one limit that must remain visible.
FDA defines interoperable medical devices through the ability to exchange and use information with another product, system or device. The manufacturer should identify partners, users, environments, clinical workflow and the purpose of exchanged information. It also exposes assumptions about partners, users and failure behaviour.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about the intended scenario frames design? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for the intended scenario frames design. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for the intended scenario frames design, its identifier or version context, and one limit that must remain visible.
CHAPTER 3 OF 17 · Define the scenario
3. Externally facing interfaces need description
A successful connection must preserve meaning, timing, integrity and appropriate use. Premarket information should describe each relevant electronic interface and whether it is for manufacturer-only, specified or broader use. Standards can support the interface while product-specific evidence remains necessary.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about externally facing interfaces need description? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for externally facing interfaces need description. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for externally facing interfaces need description, its identifier or version context, and one limit that must remain visible.
Labeling and interface documentation are part of the safety case. A device may transmit, receive or exchange information bidirectionally, and each direction can create different hazards. End-to-end testing should follow the intended interoperable scenario.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about direction of exchange matters? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for direction of exchange matters. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for direction of exchange matters, its identifier or version context, and one limit that must remain visible.
Interoperability becomes safe when an electronic interface is treated as part of the medical-device design. Data definitions, units, codes, ranges, timestamps and patient association help receiving systems interpret information correctly. This turns connectivity from a convenience into an engineering responsibility.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about information models preserve meaning? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for information models preserve meaning. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for information models preserve meaning, its identifier or version context, and one limit that must remain visible.
FDA defines interoperable medical devices through the ability to exchange and use information with another product, system or device. Sampling, transmission, processing and display delays can affect alarms, monitoring, control and clinical decisions. It also exposes assumptions about partners, users and failure behaviour.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about timeliness is a safety property? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for timeliness is a safety property. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for timeliness is a safety property, its identifier or version context, and one limit that must remain visible.
A successful connection must preserve meaning, timing, integrity and appropriate use. Error detection, completeness checks and handling of corrupted or missing messages support reliable exchange. Standards can support the interface while product-specific evidence remains necessary.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about integrity must survive the route? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for integrity must survive the route. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for integrity must survive the route, its identifier or version context, and one limit that must remain visible.
Labeling and interface documentation are part of the safety case. Devices should define what happens during disconnection, congestion, partner failure or restoration. End-to-end testing should follow the intended interoperable scenario.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about availability needs failure behaviour? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for availability needs failure behaviour. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for availability needs failure behaviour, its identifier or version context, and one limit that must remain visible.
Interoperability becomes safe when an electronic interface is treated as part of the medical-device design. Validation, bounds checking, authentication and state management can prevent incompatible or malicious data from changing device behaviour. This turns connectivity from a convenience into an engineering responsibility.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about the interface should reject unsafe inputs? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for the interface should reject unsafe inputs. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for the interface should reject unsafe inputs, its identifier or version context, and one limit that must remain visible.
FDA defines interoperable medical devices through the ability to exchange and use information with another product, system or device. Users need clear status, source, freshness, connection state, errors and recovery instructions across the interoperable workflow. It also exposes assumptions about partners, users and failure behaviour.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about human factors connect systems? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for human factors connect systems. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for human factors connect systems, its identifier or version context, and one limit that must remain visible.
A successful connection must preserve meaning, timing, integrity and appropriate use. Interfaces create access paths and trust relationships that should be addressed through threat modelling and security controls. Standards can support the interface while product-specific evidence remains necessary.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about cybersecurity is an end-to-end concern? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for cybersecurity is an end-to-end concern. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for cybersecurity is an end-to-end concern, its identifier or version context, and one limit that must remain visible.
Labeling and interface documentation are part of the safety case. Recognized consensus standards and well-defined specifications can support interoperability but do not replace product-specific verification. End-to-end testing should follow the intended interoperable scenario.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about standards can support compatibility? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for standards can support compatibility. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for standards can support compatibility, its identifier or version context, and one limit that must remain visible.
CHAPTER 13 OF 17 · Label compatible use
13. Risk analysis follows interaction hazards
Interoperability becomes safe when an electronic interface is treated as part of the medical-device design. The evidence should connect interface failures or misuse to hazardous situations, harms, controls and residual risk. This turns connectivity from a convenience into an engineering responsibility.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about risk analysis follows interaction hazards? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for risk analysis follows interaction hazards. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for risk analysis follows interaction hazards, its identifier or version context, and one limit that must remain visible.
CHAPTER 14 OF 17 · Label compatible use
14. Testing should include representative partners
FDA defines interoperable medical devices through the ability to exchange and use information with another product, system or device. Bench and system testing should exercise expected configurations, boundary values, faults, timing and incompatible partners. It also exposes assumptions about partners, users and failure behaviour.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about testing should include representative partners? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for testing should include representative partners. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for testing should include representative partners, its identifier or version context, and one limit that must remain visible.
A successful connection must preserve meaning, timing, integrity and appropriate use. Instructions should identify interface purpose, compatible products or specifications, configuration, limitations, warnings and troubleshooting. Standards can support the interface while product-specific evidence remains necessary.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about labeling defines compatible use? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for labeling defines compatible use. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for labeling defines compatible use, its identifier or version context, and one limit that must remain visible.
Labeling and interface documentation are part of the safety case. Software, protocol, certificate, network or partner changes can alter compatibility and require regression testing and change assessment. End-to-end testing should follow the intended interoperable scenario.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about updates can break interoperability? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for updates can break interoperability. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for updates can break interoperability, its identifier or version context, and one limit that must remain visible.
CHAPTER 17 OF 17 · Label compatible use
17. A complete interface receipt supports review
Interoperability becomes safe when an electronic interface is treated as part of the medical-device design. Record interface identity, protocol, data model, direction, timing, integrity, partners, hazards, controls, tests, labeling, cybersecurity and version. This turns connectivity from a convenience into an engineering responsibility.
Try this
Evidence question: Which official guidance passage, test record or decision supports the point about a complete interface receipt supports review? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the function, version, date and one limit for a complete interface receipt supports review. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for a complete interface receipt supports review, its identifier or version context, and one limit that must remain visible.
Contents · Previous chapter · Continue at the Science Learning Hub
A connected system becomes dependable when every hand-off has a contract
Safe interoperability depends on explicit assumptions. Interface specifications, risk controls and realistic testing allow another reader to see what can connect, what information means and how failure is handled.
Save the device and software version, interoperable scenario, partner classes, physical and logical interfaces, protocol and standards versions, data dictionary, units and time handling, performance and availability requirements, trust model, hazards, controls, test configurations and results, labeling and change history.
| Reading object | What it can support | Question to keep visible |
|---|---|---|
| Scenario | Defines the intended connected use | Which partners and users? |
| Interface contract | Defines data, timing and behaviour | How are errors handled? |
| System test | Exercises exchange and use | Were representative faults tested? |
| Labeling | Communicates compatibility and limits | Which versions and configurations? |
Sources and next reading
Substantive resource claims in this article were checked against the primary pages below. A structured record is a route into evidence; it does not by itself prove a scientific conclusion. Recheck the live record, evidence labels and release context before using it in assessed work or research.
For a classroom enquiry, save a short research receipt containing the question, search terms, selected object, exact identifier, version, access date and the evidence boundary you observed. Add the file or page that supports each statement. This small routine turns browsing into accountable science learning and gives a teacher, classmate or future analyst a route they can independently follow.
Before sharing the conclusion, ask another reader to retrace the route without verbal hints. If they reach a different version, file or interpretation, improve the receipt and narrow the claim. Reproducibility begins with this practical check. It teaches careful reading, supports fair collaboration and keeps uncertainty visible while evidence moves from an online service into notes, analysis and a final explanation.
A useful final review separates five questions. What object was found? Which organisation or repository maintains it? What exact evidence was inspected? Which statement does that evidence support? What remains uncertain? Answer each question in one sentence, then connect every answer to a visible field, file or source page. This review catches common mistakes: citing a collection when a file supplied the value, treating the newest release as the analysed release, confusing permission with scientific suitability, or turning a discovery count into a conclusion. It also gives students a calm way to improve work. A missing detail becomes a next research step instead of an invitation to guess. When the route is complete, the final explanation can stay simple because the identifiers, dates, versions, limitations and supporting evidence are already organised underneath it.
Primary sources
- FDA Interoperable Medical Devices Guidance — accessed 25 October 2026.
- FDA Interoperability Webinar Slides — accessed 25 October 2026.
- FDA Cybersecurity in Medical Devices — accessed 25 October 2026.
- FDA Recognized Consensus Standards — accessed 25 October 2026.
- FDA Device Software Premarket Guidance — accessed 25 October 2026.